Technology
Health
Medical

Neurotrope

$5.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.18%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Neurotrope and other stocks, options, ETFs, and crypto commission-free!

About NTRP

Neurotrope, Inc. Common Stock, also called Neurotrope, is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. Read More The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY.

Employees
6
Headquarters
New York, New York
Founded
2011
Market Cap
70.94M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
103.89K
High Today
$5.77
Low Today
$5.36
Open Price
$5.39
Volume
72.98K
52 Week High
$10.50
52 Week Low
$3.33

Collections

Technology
Health
Medical
Biopharmaceutical
Pharmaceutical
2013 IPO
US
North America
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.